U-BX Technology Ltd focuses on providing value-added services using artificial intelligence-driven technology to businesses in the insurance industry, including insurance carriers and brokers... Show more
U-BX Technology Ltd. (UBXG) is a technology company specializing in artificial intelligence-driven value-added services for the insurance industry in China. The firm offers digital promotion services, risk assessment tools like its Magic Mirror algorithm for payout risk calculation, and bundled benefits such as auto maintenance and vehicle notifications to insurance carriers and brokers. Founded in 2018 and headquartered in Beijing, U-BX operates in the competitive software-infrastructure sector, leveraging AI to enhance underwriting and customer engagement. Its fundamentals, including a low price-to-sales ratio of 0.09 and exposure to China's vast insurance market, have supported recent stock price recovery as investor focus shifts toward undervalued tech plays with growth potential in insurtech.
Over the last 30 days, UBXG stock climbed +79%, from a close of $1.87 around early March to $3.34 by March 31. The movement was volatile and trend-driven, with low daily volumes giving way to a massive spike of over 296,000 shares on the final day, pushing the price from an open of $1.78 to a high of $3.34.
For the quarter, the stock advanced +61%, rising from $2.08 in early January to the recent $3.34 close. Performance was range-bound early on before accelerating upward, trading within the lower end of its 52-week range of $1.45-$4.55. The 50-day moving average stands at approximately $1.82, confirming the bullish breakout.
The sharp 30-day rally in UBXG stock stemmed primarily from increased trading activity and speculative interest in small-cap tech names. Volume exploded on March 31, reaching 296,400 shares—far exceeding the average of around 6,000—amid a intraday surge of over 100%, signaling momentum buying. This occurred against a backdrop of broader market trends favoring AI and insurtech plays, where U-BX's specialized services gained attention. No specific company news like earnings releases or partnerships emerged in the period, but the stock's negative beta of -1.38 amplified gains during risk-on sentiment shifts. Low float of 22.5 million shares exacerbated the upward volatility, as limited supply met rising demand.
The quarterly uptrend built on sustained narratives around U-BX's positioning in China's insurance tech space, where AI adoption is accelerating. Earlier pressures from Nasdaq minimum bid price compliance notices (resolved via a prior 1-for-16 reverse split in late 2024) weighed on sentiment, but stabilization above $1.45 drew institutional interest. Macro factors, including stabilizing interest rates and demand for cost-efficient insurtech solutions amid economic recovery in China, supported the rebound. Declining short interest and improved YTD returns of +67% reflected shifting investor behavior toward micro-cap recovery stories. Cumulative impact came from sector tailwinds outweighing profitability challenges like a -9.16% profit margin.
Tickeron’s Trending AI Robots page showcases the platform's top-performing AI trading bots out of hundreds that analyze and trade thousands of tickers across various markets. These curated bots stand out based on recent performance metrics, win rates, and relevance to current market conditions. Strategies range from short-term scalping to long-term trend following, with varying timeframes, risk levels, and asset focuses like stocks, ETFs, or forex. Users can explore detailed stats, backtests, and live results to identify bots aligning with their trading style. Check out the Trending AI Robots page to discover automated tools potentially suited for tracking volatile names like UBXG.
Investors should monitor upcoming fiscal year-end results for June 30, as profitability metrics like ROA (-10.28%) and ROE (-16.53%) remain key focus areas. Nasdaq compliance remains critical given prior notices, with bid price and market value thresholds under scrutiny. Industry trends in Chinese insurtech, including AI regulatory developments and competition, could sway sentiment. Macro conditions such as U.S.-China trade dynamics, interest rates impacting insurance demand, and overall tech sector rotation warrant attention. Potential strategic moves like partnerships or shelf offerings may introduce volatility, alongside volume trends signaling sustained interest.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
UBXG saw its Momentum Indicator move above the 0 level on June 10, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator turned positive. In of the 39 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for UBXG just turned positive on May 22, 2026. Looking at past instances where UBXG's MACD turned positive, the stock continued to rise in of 20 cases over the following month. The odds of a continued upward trend are .
Following a +10 3-day Advance, the price is estimated to grow further. Considering data from situations where UBXG advanced for three days, in of 96 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 14 cases where UBXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for UBXG moved out of overbought territory on June 17, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 similar instances where the indicator moved out of overbought territory. In of the 10 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 10 cases where UBXG's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UBXG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
UBXG broke above its upper Bollinger Band on June 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UBXG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.349) is normal, around the industry mean (47.019). UBXG's P/E Ratio (856.281) is considerably higher than the industry average of (64.523). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.549). UBXG has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.048). P/S Ratio (0.242) is also within normal values, averaging (28.423).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UBXG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AdvertisingMarketingServices